Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Abhijit Pawar

Abhijit Pawar is the Chairman of AP Globale.

Abhijit Pawar Headquarter Location

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Abhijit Pawar News

Coronavirus pandemic: COVID-19 test kit maker Mylab gets funding from Adar Poonawalla, Abhijit Pawar

Apr 2, 2020

The Pune-based company to deploy the funds to scale up operations and quicken delivery of testing kits for COVID-19. Representative Image Mylab Discovery Solutions, the first Indian company to get commercial approval to supply COVID-19 test kits, on April 2 said it received funding from Adar Poonawalla, CEO of Serum Institute of India, and Abhijit Pawar, Chairman of AP Globale (APG). The company didn't disclose details like the quantum of funds. The Pune-based company said it will deploy the funds to scale up operations and quicken delivery of testing kits for COVID-19. COVID-19 Vaccine How does a vaccine work? A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine. How many types of vaccines are there? There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine. What does it take to develop a vaccine of this kind? Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Abhijit Pawar Investments

1 Investments

Abhijit Pawar has made 1 investments. Their latest investment was in Mylab Discovery Solutions as part of their Unattributed on April 4, 2020.

CBI Logo

Abhijit Pawar Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/2/2020

Unattributed

Mylab Discovery Solutions

Yes

1

Date

4/2/2020

Round

Unattributed

Company

Mylab Discovery Solutions

Amount

New?

Yes

Co-Investors

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.